1. Baird DD, Umbach DM, Landsedell L, et al. Dietary intervention study
to assess estrogenicity of dietary soy among postmenopausal women. J Clin Endocrinol
Metab 1995;80:1685–90. 2. Cassidy A, Bingham S, Setchell KD. Biological effects of a diet of soy
protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin
Nutr 1994;60:333–40. 3. Knight DC, Eden JA. A review of the clinical effects of
phytoestrogens. Obstet Gynecol 1996;87:897–904 [review]. 4. Albertazzi P, Pansini F, Bonaccorsi G, et al. The effect of dietary
soy supplementation on hot flushes. Obstet Gynecol 1998;91:6–11. 5. Albertazzi P, Pansini F, Bottazzi G, et al. Dietary soy
supplementation and phytoestrogen levels. Obstet Gynecol 1999;94:229–31. 6. Brezinski A, Adlercreutz H, Shaoul R, et al. Short-term effects of
phytoestrogen-rich diet on postmenopausal women. Menopause 1997;4:89–94. 7. Han KK, Soares JM Jr, Haidar MA, et al. Benefits of soy isoflavone
therapeutic regimen on menopausal symptoms. Obstet Gynecol 2002;99:389–94. 8. Ivarsson T, Spetz AC, Hammar M. Physical exercise and vasomotor
symptoms in postmenopausal women. Mauritas 1998;29:139–46. 9. Hammar M, Berg G, Lindgren R. Does physical exercise influence the
frequency of postmenopausal hot flushes? Acta Obstet Gynecol Scand
1990;69:409–12. 10. Slaven L, Lee C. Mood and symptom reporting among middle-aged women:
the relationship between menopausal status, hormone replacement therapy, and exercise
participation. Health Psychol 1997;16:203–8. 11. Staropoli CA, Flaws JA, Bush TL, Moulton AW. Predictors of menopausal
hot flashes. J Womens Health 1998;7:1149–55. 12. Greenberg G, Thompson SG, Meade TW. Relation between cigarette
smoking and use of hormonal replacement therapy for menopausal symptoms. J Epidemiol
Community Health 1987;41:26–9. 13. Perloff WH. Treatment of the menopause. Am J Obstet Gynecol
1949;58:684–94. 14. Gozan HA. The use of vitamin E in treatment of the menopause. NY
State J Med 1952;52:1289. 15. Christy CJ. Vitamin E in menopause: Preliminary report of
experimental and clinical study. Am J Obstet Gynecol 1945:50:84. 16. Finkler RS. The effect of vitamin E in the menopause. J Clin
Endocrinol Metab 1949;9:89–94. 17. Rubenstein BB. Vitamin E diminishes the vasomotor symptoms of
menopause. Fed Proc 1948;7:106 [abstract]. 18. Blatt MHG, Weisbader H, Kupperman HS. Vitamin E and climacteric
syndrome: failure of effective control as measured by menopausal index. Arch Intern
Med 1953;91:792–9. 19. Barton DL, Loprinzi CL, Quella SK, et al. Prospective evaluation of
vitamin E for hot flashes in breast cancer survivors. J Clin Oncol
1998;16:495–500. 20. CJ Smith. Non-hormonal control of vaso-motor flushing in menopausal
patients. Chicago Med 1964;67:193–5. 21. Nielsen FH, Penland JG. Boron supplementation of per-menopausal women
affects boron metabolism and indices associated with macromineral metabolism, hormonal status
and immune function. J Trace Elements Exp Med 1999;12:251–61. 22. Stomati M, Rubino S, Spinetti A, et al. Endocrine, neuroendocrine and
behavioral effects of oral dehydroepiandrosterone sulfate supplementation in postmenopausal
women. Gynecol Endocrinol 1999;13:15–25. 23. Barnhart KT, Freeman E, Grisso JA, et al. The effect of
dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine
profiles, lipid parameters, and health-related quality of life. J Clin Endocrinol
Metab 1999;84:3896–902. 24. Lee JR. Natural Progesterone. The multiple roles of a remarkable
hormone. Sebastipol, CA: BLL Publishing, 1993, 31–7. 25. Gaby AR. Commentary. Nutr Healing
1996;June:1,10–1. 26. Wright JV. Hormones for menopause. Nutr Healing
1996;June:1–2,9. 27. Greendale GA, Reboussin BA, Hogan P, et al. Symptom relief and side
effects of postmenopausal hormones: results from the Postmenopausal Estrogen/Progestin
Interventions Trial. Obstet Gynecol 1998;92:982–8. 28. Leonetti HB, Long S, Anasti JM. Transdermal progesterone cream for
vasomotor symptoms and postmenopausal bone loss. Obstet Gynecol
1999;94:225–8. 29. Fitzpatrick LA, Pace C, Wiita B. Comparison of regimens containing
oral micronized progesterone or medroxyprogesterone acetate on quality of life in
postmenopausal women: a cross-sectional survey. J Women’s Health Gender-Based
Med 2000;9:381–7. 30. Bullock JL, Massey FM, Gambrell RD Jr. Use of medroxyprogesterone
acetate to prevent menopausal symptoms. Obstet Gynecol 1975;46:165–8. 31. Morrison JC, Martin DC, Blair RA, et al. The use of
medroxyprogesterone acetate for relief of climateric symptoms. Am J Obstet Gynecol
1980 138:99–104. 32. Schiff I, Tulchinsky D, Cramer D, Ryan KJ. Oral medroxyprogesterone
in the treatment of postmenopausal symptoms. JAMA 1980;244:1443–5. 33. Liske E. Therapeutic efficacy and safety of Cimicifuga
racemosa for gynecological disorders. Advances Therapy 1998;15:45–53. 34. Lieberman S. A review of the effectiveness of Cimicifuga
racemosa (black cohosh) for the symptoms of menopause. J Womens Health
1998;7:525–9. 35. Crawford AM. The Herbal Menopause Book. Freedom, CA:
Crossing Press, 1996. 36. Hudson TS, Standish L, Breed C, et al. Clinical and endocrinological
effects of a menopausal botanical formula. J Naturopathic Med
1997;7(1):73–7. 37. Hirata JD, Swiersz LM, Zell B, et al. Does dong quai have estrogenic
effects in postmenopausal women? A double-blind, placebo-controlled trial. Fertil
Steril 1997;68:981–6. 38. Nestel PJ, Pomeroy S, Kay S, et al. Isoflavones from red clover
improve systemic arterial compliance but not plasma lipids in menopausal women. J Clin
Endocrinol Metab 1999;84:895–8. 39. Tice JA, Ettinger B, Ensrud K, et al. Phytoestrogen supplements for
the treatment of hot flashes: the Isoflavone Clover Extract (ICE) Study: a randomized
controlled trial. JAMA 2003;290:207–14. 40. van de Weijer PHM, Barentsen R. Isoflavones from red clover
(Promensil®) significantly reduce menopausal hot flush symptoms compared with placebo.
Maturitas 2002;42:187–93. 41. Duke JA. CRC Handbook of Medicinal Herbs. Boca Raton, FL:
CRC Press, 1985, 420–1 [review]. 42. De Leo V, Lanzetta D, Cazzavacca R, Morgante G. [Treatment of
neurovegetative menopausal symptoms with a phytotherapeutic agent] [Article in Italian]
Minerva Ginecol 1998;50:207–11. 43. Grube B, Walper A, Wheatley D. St. John’s Wort extract:
efficacy for menopausal symptoms of psychological origin. Adv Ther
1999;16:177–86. 44. Wiklund IK, Mattson LA, Lindgren R, et al. Effects of a standardized
ginseng extract on quality of life and psychological parameters in symptomatic postmenopausal
women: a double-blind, placebo-controlled trial. Int J Clin Pharm Res
1999;19:89–99. 45. Warnecke G. Psychosomatic dysfunctions in the female climacteric.
Clinical effectiveness and tolerance of kava extract WS 1490. Fortschr Med
1991;119–22 [in German]. 46. De Leo V, la Marca A, Morgante G, et al. Evaluation of combining kava
extract with hormone replacement therapy in the treatment of postmenopausal anxiety.
Maturitas 2001;39:185–8. 47. Toriizuka K, Okumura M, Iijima K, et al. Acupuncture inhibits the
decrease in brain catecholamine contents and the impairment of passive avoidance task in
ovariectomized mice. Acupunct Electrother Res 1999;24:45–57. 48. Wyon Y, Lindgren R, Hammar M, Lundeberg T. Acupuncture against
climacteric disorders? Lower number of symptoms after menopause. Lakartidningen
1994;91:2318–22 [in Swedish]. 49. Popivanov P. Menopausal indices as criteria for the effectiveness of
acupuncture treatment of the climacteric syndrome. Vutr Boles 1983;22:110–3 [in
Bulgarian]. 50. Kraft K, Coulon S. Effect of a standardized acupuncture treatment on
complaints, blood pressure and serum lipids of hypertensive, postmenopausal women. A
randomized, controlled clinical study. Forsch Komplementarmed 1999;6:74–9 [in
German]. 51. Lianzhong W, Xin Z. 300 cases of menopausal syndrome treated by
acupuncture. J Trad Chin Med 1998;18:259–62. |